top of page
Executive Spotlights

Merck to Acquire Caraway Therapeutics for $610M

Rahway, NJ & Cambridge, MA, November 21, 2023 (Business Wire) -- Merck (NYSE: MRK), also known as MSD outside of the United States and Canada, and Caraway Therapeutics, Inc. declare a definitive agreement for Merck, to purchase Caraway Therapeutics for a total potential of up to $610 million.

Read full article here.

Recent Posts

See All
Life Science Headlines
bottom of page